Jeff Tosoian, MD, MPH

Society of Urologic Oncology (NCI T32) Fellow


Dr. Tosoian grew up in southeast Michigan and attended the University of Michigan as an undergraduate. He earned his MD and Master of Public Health in epidemiological and biostatistical methods for clinical research at Johns Hopkins. He completed residency training in urology at the Johns Hopkins Brady Urological Institute before returning to the University of Michigan in 2018 as a clinical lecturer and fellow in urologic oncology.

His research focuses on development and use of diagnostic and prognostic tools, including blood-, urine-, and tissue-based biomarkers, to guide the diagnosis and management of prostate, kidney, and other genitourinary cancers. He has authored more than 100 publications in high-impact journals including JAMA, JAMA Oncology, and Journal of Clinical Oncology.

Honors & Awards

2016 - Patrick C. Walsh Award for Clinical Research, Johns Hopkins University School of Medicine
2017 - Frank Coulson Award for Clinical Excellence, Johns Hopkins Hospital
2019 - Coffey-Krane Prize for Best Research, British Journal of Urology International
2019- Top Reviewer in Clinical Medicine, Web of Science
2019 - Inaugural Clark Family Fellow for Kidney Cancer Research


Medical School: Johns Hopkins University School of Medicine 

Residency: Johns Hopkins University Brady Urological Institute

Additional: Master of Public Health (MPH), Biostatistics and Epidemiology, Johns Hopkins Bloomberg School of Public Health